CAPTRUST Financial Advisors
RCKT icon

CAPTRUST Financial Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Buy
38,365
+5,586
+17% +$18.6K ﹤0.01% 2988
2026
Q1 		$117K Buy
+32,779
New +$130K ﹤0.01% 2788
2022
Q3 		– Sell
-104
Closed -$1K – 3592
2022
Q2 		$1K Buy
+104
New +$1.24K ﹤0.01% 4726
2022
Q1 		– Sell
-39
Closed -$1K – 5095
2021
Q4 		$1K Buy
39
+18
+86% +$491 ﹤0.01% 4619
2021
Q3 		$1K Sell
21
-21
-50% -$764 ﹤0.01% 4472
2021
Q2 		$2K Sell
42
-34
-45% -$1.48K ﹤0.01% 4199
2021
Q1 		$3K Buy
+76
New +$4.17K ﹤0.01% 3934

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

CAPTRUST Financial Advisors's RCKT Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Rocket Pharmaceuticals (RCKT) stake by 17% in Q2 2026, buying an estimated $18.6K and bringing the position to 38,365 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #2988.

CAPTRUST Financial Advisors first reported a position in RCKT in Q1 2021 and has held it in 7 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • CAPTRUST Financial Advisors held 38,365 shares of Rocket Pharmaceuticals worth $131K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 5,586 Rocket Pharmaceuticals shares in Q2 2026, an estimated $18.6K.
  • Rocket Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2988 holding.
  • CAPTRUST Financial Advisors first reported a position in Rocket Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.